The Patent Finder

Maintenance fees coming due

Alnylam Pharmaceuticals, Inc.

62 maintenance fees come due in the 12 months from Nov 19, 2026, the next on Nov 19, 2026. Unpaid by May 19, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 9,035,041Process for Triphosphate Oligonucleotide Synthesis
In force
Fee due Nov 19, 2026
Lapses if unpaid May 19, 2027
 · High confidence
Alnylam Pharmaceuticals, Inc.In forceNov 19, 2026May 19, 2027High confidence
US 11,679,158Biodegradable Lipids for the Delivery of Active Agents
In force
Fee due Dec 20, 2026
Lapses if unpaid Jun 21, 2027
 · Medium confidence
Alnylam Pharmaceuticals, Inc.In forceDec 20, 2026Jun 21, 2027Medium confidence
US 9,061,063Biodegradable Lipids for the Delivery of Active Agents
In force
Fee due Dec 23, 2026
Lapses if unpaid Jun 23, 2027
 · High confidence
Alnylam Pharmaceuticals, Inc.In forceDec 23, 2026Jun 23, 2027High confidence
US 9,062,310Compositions and Methods for Inhibiting Expression of Factor VII Gene
In force
Fee due Dec 23, 2026
Lapses if unpaid Jun 23, 2027
 · High confidence
Alnylam Pharmaceuticals, Inc.In forceDec 23, 2026Jun 23, 2027High confidence
US 11,685,918PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
In force
Fee due Dec 27, 2026
Lapses if unpaid Jun 28, 2027
 · High confidence
Alnylam Pharmaceuticals, Inc.In forceDec 27, 2026Jun 28, 2027High confidence
US 9,068,184Compositions and Methods for Inhibition of Expression of Protein C (PROC) Genes
In force
Fee due Dec 30, 2026
Lapses if unpaid Jun 30, 2027
 · High confidence
Alnylam Pharmaceuticals, Inc.In forceDec 30, 2026Jun 30, 2027High confidence
US 10,337,010ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
In force
Fee due Jan 2, 2027
Lapses if unpaid Jul 2, 2027
 · Medium confidence
Alnylam Pharmaceuticals, Inc.In forceJan 2, 2027Jul 2, 2027Medium confidence
US 9,090,895Compositions and Methods for Inhibiting Expression of the Hamp Gene
In force
Fee due Jan 28, 2027
Lapses if unpaid Jul 28, 2027
 · Medium confidence
Alnylam Pharmaceuticals, Inc.In forceJan 28, 2027Jul 28, 2027Medium confidence
US 10,369,226Biodegradable Lipids for the Delivery of Active Agents
In force
Fee due Feb 6, 2027
Lapses if unpaid Aug 6, 2027
 · High confidence
Alnylam Pharmaceuticals, Inc.In forceFeb 6, 2027Aug 6, 2027High confidence
US 10,370,666Ketohexokinase (KHK) Irna Compositions and Methods of Use Thereof
In force
Fee due Feb 6, 2027
Lapses if unpaid Aug 6, 2027
 · Medium confidence
Alnylam Pharmaceuticals, Inc.In forceFeb 6, 2027Aug 6, 2027Medium confidence
52 more maintenance fees coming due in the 12 months from Nov 19, 2026 · Pro
10 of 62 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited